The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review-Reference-Cited by-同舟云学术

The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review

Published:2015-07-30 Issue:1 Volume:10 Page:
ISSN:1750-1172
Container-title:Orphanet Journal of Rare Diseases
language:en
Short-container-title:Orphanet J Rare Dis

Author:

Schuller Y.,Hollak C. E. M.,Biegstraaten M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Genetics(clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13023-015-0305-y.pdf

Reference41 articles.

1. Rinaldi A. Adopting an orphan. EMBO Rep. 2005;6:507–10.

2. OrphaNet. http://www.orpha.net/consor/cgi-bin/index.php?lng=EN. Accessed May 2015.

3. Excellence NIfC. NICE Citizens Council Report on Ultra Orphan Drugs. London 2004.

4. Orphan incentives. European Medicines Agency. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000393.jsp. Accessed May 2015.

5. Simoens S. Pricing and reimbursement of orphan drugs: the need for more transparency. Orphanet J Rare Dis. 2011;6:42.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Designing a Roadmap for Health Technology Assessment Implementation in Algeria;Cureus;2024-07-28

2. Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review;PharmacoEconomics;2024-04-14

3. Economic Burden of Gaucher Disease at a Tertiary Care Public Hospital in Mumbai;Indian Journal of Pediatrics;2023-07-24

4. Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?;Value in Health;2023-07

5. Health technology assessment in Türkiye: Current status and perspectives on future implementation;Health Policy and Technology;2023-03